Escalon Medical Corp. (ESMC)
USD 0.16
(-11.11%)
USD 0.16
(-11.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -58.46 Thousand USD | -107.19% |
| 2023 | 813.43 Thousand USD | 516.91% |
| 2022 | 364.63 Thousand USD | 480.44% |
| 2021 | 289.24 Thousand USD | -20.45% |
| 2020 | -244.55 Thousand USD | 110.08% |
| 2019 | -182.52 Thousand USD | -124.06% |
| 2018 | 758.76 Thousand USD | 266.49% |
| 2017 | -580.56 Thousand USD | 59.15% |
| 2016 | -1.11 Million USD | -7.48% |
| 2015 | -1.03 Million USD | -201.06% |
| 2014 | -344.92 Thousand USD | 69.69% |
| 2013 | -1.13 Million USD | 35.03% |
| 2012 | -1.75 Million USD | 63.04% |
| 2011 | -4.36 Million USD | -111.51% |
| 2010 | -2.31 Million USD | 9.17% |
| 2009 | -12.79 Million USD | 50.37% |
| 2008 | -14.33 Million USD | -178.66% |
| 2007 | 6.38 Million USD | 268.28% |
| 2006 | -2.59 Million USD | -1.24% |
| 2005 | -294.86 Thousand USD | -205.78% |
| 2004 | 3.5 Million USD | 18.21% |
| 2003 | 2.76 Million USD | 47.35% |
| 2002 | 1.99 Million USD | -26.02% |
| 2001 | 2.69 Million USD | 204.8% |
| 2000 | -1.18 Million USD | -1197.29% |
| 1999 | 700 Thousand USD | -200.0% |
| 1998 | 200 Thousand USD | 103.92% |
| 1997 | -5 Million USD | -34.21% |
| 1996 | -3.5 Million USD | 13.64% |
| 1995 | -4.1 Million USD | 27.87% |
| 1994 | -5.9 Million USD | -19.61% |
| 1993 | -5.1 Million USD | -37.84% |
| 1992 | -3.7 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -15.64 Thousand USD | -101.6% |
| 2024 Q4 | 157.55 Thousand USD | 202.96% |
| 2024 Q2 | 92.29 Thousand USD | 2098.38% |
| 2024 Q3 | -153.03 Thousand USD | -265.82% |
| 2023 Q4 | 215.79 Thousand USD | -64.1% |
| 2023 Q3 | 601.1 Thousand USD | 5180.76% |
| 2023 Q1 | -304.41 Thousand USD | -554.95% |
| 2023 Q2 | 11.38 Thousand USD | 103.74% |
| 2023 FY | - USD | 516.91% |
| 2022 Q3 | -280.39 Thousand USD | -658.47% |
| 2022 Q1 | 335.36 Thousand USD | 66.97% |
| 2022 Q4 | 66.91 Thousand USD | 123.86% |
| 2022 FY | - USD | 480.44% |
| 2022 Q2 | -36.96 Thousand USD | -111.02% |
| 2021 Q3 | -121.29 Thousand USD | -205.66% |
| 2021 Q1 | -179.73 Thousand USD | 60.22% |
| 2021 FY | - USD | -20.45% |
| 2021 Q2 | 114.79 Thousand USD | 163.87% |
| 2021 Q4 | 200.85 Thousand USD | 265.6% |
| 2020 Q4 | -451.79 Thousand USD | -301.83% |
| 2020 Q3 | -112.43 Thousand USD | -105.73% |
| 2020 Q2 | -54.65 Thousand USD | -108.58% |
| 2020 FY | - USD | 110.08% |
| 2020 Q1 | 637.26 Thousand USD | 2319.28% |
| 2019 Q4 | 26.34 Thousand USD | 0.54% |
| 2019 Q3 | 26.2 Thousand USD | 112.92% |
| 2019 Q2 | -202.82 Thousand USD | -632.23% |
| 2019 Q1 | -27.69 Thousand USD | -129.08% |
| 2019 FY | - USD | -124.06% |
| 2018 Q3 | -78.77 Thousand USD | -110.4% |
| 2018 Q1 | -15.21 Thousand USD | 86.6% |
| 2018 FY | - USD | 266.49% |
| 2018 Q4 | 95.25 Thousand USD | 220.92% |
| 2018 Q2 | 757.31 Thousand USD | 5076.47% |
| 2017 Q2 | -31.31 Thousand USD | 91.6% |
| 2017 Q3 | -62.92 Thousand USD | -100.96% |
| 2017 Q4 | -113.57 Thousand USD | -80.49% |
| 2017 FY | - USD | 59.15% |
| 2017 Q1 | -372.84 Thousand USD | 25.42% |
| 2016 Q3 | -70.23 Thousand USD | 72.66% |
| 2016 Q2 | -256.87 Thousand USD | 10.95% |
| 2016 Q4 | -499.94 Thousand USD | -611.81% |
| 2016 Q1 | -288.44 Thousand USD | 46.46% |
| 2016 FY | - USD | -7.48% |
| 2015 Q3 | 11.1 Thousand USD | 115.18% |
| 2015 FY | - USD | -201.06% |
| 2015 Q1 | -437.02 Thousand USD | -5.8% |
| 2015 Q2 | -73.15 Thousand USD | 83.26% |
| 2015 Q4 | -538.72 Thousand USD | -4951.16% |
| 2014 Q2 | -87.5 Thousand USD | -315.38% |
| 2014 Q3 | 115.21 Thousand USD | 231.67% |
| 2014 Q4 | -413.05 Thousand USD | -458.51% |
| 2014 FY | - USD | 69.69% |
| 2014 Q1 | 40.62 Thousand USD | 110.99% |
| 2013 Q3 | -285.52 Thousand USD | -352.82% |
| 2013 Q2 | 112.93 Thousand USD | 119.09% |
| 2013 Q1 | -591.64 Thousand USD | -71.83% |
| 2013 FY | - USD | 35.03% |
| 2013 Q4 | -369.83 Thousand USD | -29.53% |
| 2012 Q3 | -453.05 Thousand USD | 41.25% |
| 2012 Q4 | -344.31 Thousand USD | 24.0% |
| 2012 FY | - USD | 63.04% |
| 2012 Q1 | -484.61 Thousand USD | 82.91% |
| 2012 Q2 | -771.12 Thousand USD | -59.12% |
| 2011 Q2 | -632.69 Thousand USD | -3.9% |
| 2011 FY | - USD | -111.51% |
| 2011 Q4 | -2.83 Million USD | -331.45% |
| 2011 Q3 | -657.32 Thousand USD | -3.89% |
| 2011 Q1 | -608.93 Thousand USD | 50.58% |
| 2010 Q1 | -288.51 Thousand USD | 76.45% |
| 2010 Q4 | -1.23 Million USD | -10675.15% |
| 2010 FY | - USD | 9.17% |
| 2010 Q3 | -11.43 Thousand USD | 98.38% |
| 2010 Q2 | -707.09 Thousand USD | -145.08% |
| 2009 Q4 | -1.22 Million USD | -246.1% |
| 2009 FY | - USD | 50.37% |
| 2009 Q3 | -354.03 Thousand USD | 41.25% |
| 2009 Q2 | -602.65 Thousand USD | -82.14% |
| 2009 Q1 | -330.88 Thousand USD | 97.13% |
| 2008 Q2 | -554.38 Thousand USD | 25.83% |
| 2008 Q4 | -11.51 Million USD | -567.72% |
| 2008 Q3 | -1.72 Million USD | -211.08% |
| 2008 FY | - USD | -178.66% |
| 2008 Q1 | -747.5 Thousand USD | 34.86% |
| 2007 Q3 | 8.45 Million USD | 2739.91% |
| 2007 FY | - USD | 268.28% |
| 2007 Q4 | -1.14 Million USD | -113.57% |
| 2007 Q2 | -320.23 Thousand USD | 46.31% |
| 2007 Q1 | -596.44 Thousand USD | -183.7% |
| 2006 Q3 | -976.32 Thousand USD | -2.49% |
| 2006 Q1 | -1.4 Million USD | 39.44% |
| 2006 Q2 | -952.62 Thousand USD | 32.05% |
| 2006 Q4 | 712.59 Thousand USD | 172.99% |
| 2006 FY | - USD | -1.24% |
| 2005 Q4 | -2.31 Million USD | -4048.95% |
| 2005 Q3 | -55.79 Thousand USD | 81.03% |
| 2005 Q2 | -294.17 Thousand USD | -237.18% |
| 2005 Q1 | 214.44 Thousand USD | -71.48% |
| 2005 FY | - USD | -205.78% |
| 2004 Q1 | 841.89 Thousand USD | -12.0% |
| 2004 Q4 | 751.96 Thousand USD | 157.86% |
| 2004 Q3 | 291.62 Thousand USD | -71.54% |
| 2004 Q2 | 1.02 Million USD | 21.71% |
| 2004 FY | - USD | 18.21% |
| 2003 Q1 | 538.87 Thousand USD | 7.52% |
| 2003 Q3 | 657.7 Thousand USD | 38.85% |
| 2003 FY | - USD | 47.35% |
| 2003 Q4 | 956.73 Thousand USD | 12.08% |
| 2003 Q2 | 614.81 Thousand USD | 14.09% |
| 2002 Q4 | 501.2 Thousand USD | -11.2% |
| 2002 FY | - USD | -26.02% |
| 2002 Q3 | 564.4 Thousand USD | 37.22% |
| 2002 Q2 | 411.32 Thousand USD | -12.3% |
| 2002 Q1 | 469.01 Thousand USD | 241.53% |
| 2001 FY | - USD | 204.8% |
| 2001 Q2 | 741.95 Thousand USD | -5.2% |
| 2001 Q1 | 701.64 Thousand USD | 6716.51% |
| 2001 Q4 | -335.13 Thousand USD | -131.91% |
| 2001 Q3 | 698.99 Thousand USD | 44.83% |
| 2000 Q3 | -78.34 Thousand USD | -0.6% |
| 2000 Q2 | -600 Thousand USD | 95.24% |
| 2000 Q1 | -300 Thousand USD | -800.0% |
| 2000 FY | - USD | -1197.29% |
| 2000 Q4 | -14.1 Thousand USD | 88.63% |
| 1999 Q4 | 200 Thousand USD | 137.5% |
| 1999 FY | - USD | -200.0% |
| 1999 Q1 | 200 Thousand USD | 0.0% |
| 1999 Q2 | 200 Thousand USD | 0.0% |
| 1999 Q3 | 66 Thousand USD | -500.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1998 FY | - USD | 103.92% |
| 1998 Q4 | 200 Thousand USD | 100.0% |
| 1998 Q2 | - USD | -100.0% |
| 1998 Q1 | 100 Thousand USD | 102.44% |
| 1997 Q3 | -300 Thousand USD | 25.0% |
| 1997 Q4 | -4.1 Million USD | -1266.67% |
| 1997 Q1 | -200 Thousand USD | 50.0% |
| 1997 FY | - USD | -34.21% |
| 1997 Q2 | -400 Thousand USD | -100.0% |
| 1996 Q4 | -300 Thousand USD | 77.78% |
| 1996 Q3 | -1.7 Million USD | -157.14% |
| 1996 Q2 | -600 Thousand USD | 12.5% |
| 1996 Q1 | -700 Thousand USD | 38.46% |
| 1996 FY | - USD | 13.64% |
| 1995 Q2 | -1 Million USD | 0.0% |
| 1995 FY | - USD | 27.87% |
| 1995 Q4 | -1.3 Million USD | -85.71% |
| 1995 Q3 | -600 Thousand USD | 36.36% |
| 1995 Q1 | -1 Million USD | 31.25% |
| 1994 Q2 | -1.6 Million USD | -45.45% |
| 1994 Q3 | -1.5 Million USD | 6.25% |
| 1994 Q1 | -1.1 Million USD | 8.33% |
| 1994 FY | - USD | -19.61% |
| 1994 Q4 | -1.5 Million USD | -6.67% |
| 1993 Q3 | -1.2 Million USD | 20.0% |
| 1993 FY | - USD | -37.84% |
| 1993 Q2 | -1.5 Million USD | -25.0% |
| 1993 Q4 | -1.2 Million USD | 0.0% |
| 1993 Q1 | -1.2 Million USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 78.686% |
| IR-Med Inc. | -4.89 Million USD | 98.805% |
| Polarean Imaging plc | -11.19 Million USD | 99.478% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 112.819% |
| Avitar, Inc. | -1.66 Million USD | 96.495% |
| AVITA Medical, Inc. | -39.56 Million USD | 99.852% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 94.978% |
| Össur hf. | 137.38 Million USD | 100.043% |
| Zecotek Photonics Inc. | -3.44 Million USD | 98.302% |
| QHSLab, Inc. | -91.29 Thousand USD | 35.963% |
| Wellstar International, Inc. | -1.35 Million USD | 95.69% |
| Össur hf. | 137.38 Million USD | 100.043% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 100.598% |
| Aurora Spine Corporation | -454.37 Thousand USD | 87.134% |
| BrainsWay Ltd. | -2.31 Million USD | 97.47% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 99.377% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 101.059% |
| Vivos Inc. | -2.79 Million USD | 97.907% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.983% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 70.428% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 96.496% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 84.571% |
| Nanomix Corporation | -8.13 Million USD | 99.282% |
| Theraclion SA | -2.05 Million USD | 97.149% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 91.731% |
| Positron Corporation | -1.45 Million USD | 95.974% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 96.605% |
| Lombard Medical, Inc. | -28.06 Million USD | 99.792% |
| ALR Technologies Inc. | -6.4 Million USD | 99.087% |
| Stratec SE | 39.91 Million USD | 100.146% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 157.915% |
| Heart Tronics, Inc. | -14.85 Million USD | 99.607% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 50.565% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 99.56% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 99.361% |
| VMS Rehab Systems, Inc. | -68.55 USD | -85182.276% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 98.13% |
| Ingen Technologies, Inc. | -8639.00 USD | -576.71% |
| Odyssey Group International, Inc. | -2.13 Million USD | 97.266% |
| United American Healthcare Corporation | -59 Thousand USD | 0.914% |
| ECGI Holdings, Inc. | -2.99 Million USD | 98.045% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 90.708% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 88.627% |
| Urologix, Inc. | -6.34 Million USD | 99.078% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 95.283% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 92.368% |
| SS Innovations International, Inc. | -20.37 Million USD | 99.713% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 73.763% |
| Smith & Nephew plc | 1 Billion USD | 100.006% |
| NIOX Group Plc | 11.07 Million USD | 100.528% |
| Fuse Medical, Inc. | 1.83 Million USD | 103.185% |
| Broncus Holding Corporation | -25.19 Million USD | 99.768% |
| Brain Scientific Inc. | -7.93 Million USD | 99.263% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 99.377% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -217.723% |